Zika virus has a trick up its sleeve. As soon as contained in the physique, the virus likes to make a bee line for dendritic cells, the cells we depend on to launch an efficient immune response.
“Dendritic cells are main cells of the innate immune system,” says LJI Professor Sujan Shresta, Ph.D., a member of the LJI Middle for Infectious Illness and Vaccine Analysis. “How is that this virus so intelligent that it is capable of set up an infection in cells that might usually combat infections?”
Now Shresta and colleagues at LJI and the College of California, San Diego, have discovered that Zika virus truly forces dendritic cells to cease performing as immune cells. Utilizing a brand new mannequin of Zika virus an infection, the LJI workforce confirmed that Zika virus as an alternative makes dendritic cells churn out lipid molecules, which the virus makes use of to construct copies of itself.
“Listed below are dendritic cells doing all the things to assist a virus,” says Shresta.
The Nature Communications research is a significant step ahead within the Shresta Lab’s work to information the design of latest antiviral therapies towards many members of the Flavivirus household, together with Zika, dengue, and Japanese encephalitis virus (JEV).
“Understanding how viruses work together with human cells is vital for understanding easy methods to deal with or forestall an infection sooner or later,” says UC San Diego Professor Aaron Carlin, M.D., Ph.D., a former trainee within the Shresta Lab and co-leader of the brand new research.
Emilie Branche, Ph.D., a former postdoctoral researcher at LJI, led the hassle to develop a mannequin to raised perceive how Zika virus and dengue virus goal dendritic cells. She labored with human immune cells referred to as monocytes, which she prompted to distinguish into dendritic cells.
Branche analyzed how gene expression in these dendritic cells shifted throughout a Zika or dengue an infection. She then in contrast the adjustments in gene expression with adjustments in cells she subjected to a “mock an infection.” This comparability revealed exactly how Zika pulls off its mobile take-over.
The researchers discovered that Zika virus manipulates the genes that management lipid metabolism in dendritic cells. The virus calls in a mobile protein referred to as SREBP, which forces lipid, or fats molecule, manufacturing to enter overdrive. These lipids grew to become the constructing blocks to assemble new copies of Zika virus — copies meant to unfold via the physique, additional driving an infection.
“We confirmed that Zika, however not dengue, modulates mobile metabolism with a view to improve its replication,” says Branche.
The workforce then investigated whether or not Zika turns different cells into lipid factories. Though Zika can be recognized to focus on neuronal precursor cells, the researchers confirmed that Zika does not manipulate the lipid metabolism genes in these cells. Shresta was stunned to see these adjustments solely in dendritic cells, and he or she was stunned that Zika, not dengue, altered lipid manufacturing.
“These viruses are loopy,” says Shresta. “How these viruses manipulate host cell responses may be very virus-specific and really cell-type particular.”
The following step is to develop antivirals that cease Zika from exploiting the genes for lipid metabolism. The brand new research reveals that therapeutically silencing SREBP might maintain promise.
What to do about Zika’s cousin, dengue? As a result of these viruses are so carefully associated and overlap in so many locations, Shresta imagines a SREBP inhibitor as only one ingredient in a “cocktail” of inhibitors to deal with many various flavivirus infections.
“The extra data we will generate about these viruses, the nearer we’re to a ‘pan-flavivirus’ inhibitor,” she says.
Story Supply:
Supplies supplied by La Jolla Institute for Immunology. Authentic written by Madeline McCurry-Schmidt. Word: Content material could also be edited for fashion and size.
